Diagnostic tests are essential for disease diagnosis and global health improvement. Traditional infectious disease diagnosis was inefficient and time-consuming. Because of this flaw, the market has seen the emergence of point-of-care testing products that are quick, accurate, and portable. Poc testing allows for the faster diagnosis of infectious diseases in the patient’s immediate vicinity and provides immediate results. Several researchers are currently developing multiplex point-of-care diagnostic technologies. Increased research and development activities in infectious disease diagnostics technologies, growing awareness for early detection using specific diagnostic tests, and other factors are driving the global infectious disease diagnostics market. Infectious disease prevalence in developed and developing regions will benefit the infectious disease diagnostics market. The rising number of prescriptions for infectious disease diagnostic tests is due to the diagnosis and treatment of such diseases. These factors, along with the growing trend toward preventive medicine, are expected to drive demand for infectious disease diagnostics during the forecast period.
The rising prevalence of infectious diseases, the shift in emphasis from centralized laboratories to point-of-care testing, and increased R&D activities on infectious disease diagnostics are the primary factors driving the market growth. Scientific research and development activities in developing novel technologies and techniques such as mass spectrometry and next-generation sequencing (ngs) are changing the way rapid diagnostics are performed to detect diseases. Developing economies like India, South Korea, Brazil, and Mexico are expected to provide growth opportunities for major players in the infectious disease diagnostics market. This is due to the high disease prevalence, large patient population, improved healthcare infrastructure, rising disposable income, and growing medical tourism in these countries. The increase in the number of medical laboratories for infectious disease diagnostic testing anticipates market growth. However, apart from COVID-19 tests, these labs are also used for other infectious disease diagnostic tests such as HIV, hepatitis, tuberculosis, and dengue. Furthermore, an increase in individual awareness of early diagnosis and management of infectious diseases, as well as an increase in the number of information technology systems developing advanced diagnostic devices, is expected to provide lucrative opportunities for the expansion of the global infectious disease diagnostic market during the forecast period.
Read market research report, “Global Infectious Disease Diagnostics Market by Product (Reagents, Kits, and Consumables, Instruments, Software & Services), Test (Laboratory, POC), Technology (Immunodiagnostics, Microbiology, PCR, NGS, INAAT), Disease (COVID-19, Hepatitis, HAI, HIV, Influenza, CT/NG, HPV, TB, Other Infectious Diseases), End User (Diagnostic Laboratories, Hospitals & Clinics, Academic Research Institutes, Other End Users), & By Region- Forecast and Analysis 2021-2027” by SkyQuest
Get sample Report@https://skyquestt.com/sample-request/infectious-disease-diagnostics-market
Despite the enormous efforts put into infectious disease management, there is a high demand for low-cost, accurate, and sensitive POC products. Nanotechnology has paved the way for widespread application in the medical field. Several players have highlighted the introduction of proof-of-concept platforms based on nanoparticles and Nano devices. Because nanoparticles have a high surface area to volume ratio, they can be used in a variety of applications. Disease diagnosis can be done in real-time for patients using a small volume of samples in nanotechnology-prepared kits. As a result, the use of nanotechnology for infectious disease diagnosis provides accurate and timely results. Inadequate reimbursement is a major impediment to the growth of the infectious disease diagnostics market. The majority of diagnostic companies face a significant challenge when it comes to commercializing their tests: getting health insurers to pay for them. Furthermore, a large proportion of the global population is infected with infectious diseases such as HIV, malaria, and tuberculosis in developing countries. Lack of clinician training and poor product accessibility as a result of lower per capita expenditure have resulted in lower adoption of POC kits in low-middle income countries.
The infectious disease diagnostics market is highly fragmented, with the presence of several global and international market players. The key players are adopting different growth strategies to enhance their market presence, such as partnerships, agreements, collaborations, new product launches, geographical expansions, mergers, and acquisitions. Some of the key players in the market are Veracyte Inc., Abbott Laboratories Danaher Corporation, BioMérieux SA, F. Hoffmann-La Roche Ltd, and Becton, Dickinson and Company.
The report published by SkyQuest Technology Consulting provides in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions.
SkyQuest has segmented the Global Infectious Disease Diagnostics Market based on Product, Test, Technology, Disease, End User, and Region:
- Infectious Disease Diagnostics Market By Product (Revenue, USD Million, 2020 – 2027)
- Reagents, Kits, and Consumables
- Instruments
- Software & Services
- Infectious Disease Diagnostics Market By Test (Revenue, USD Million, 2020 – 2027)
- Laboratory
- POC
- Infectious Disease Diagnostics Market By Technology (Revenue, USD Million, 2020 – 2027)
- Immunodiagnostics
- Microbiology
- PCR
- NGS
- INAAT
- Infectious Disease Diagnostics Market By Disease (Revenue, USD Million, 2020 – 2027)
- COVID-19
- Hepatitis
- HAI
- HIV
- Influenza
- CT/NG
- HPV
- TB
- Other Infectious Diseases
- Infectious Disease Diagnostics Market By End User (Revenue, USD Million, 2020 – 2027)
- Diagnostic Laboratories
- Hospitals & Clinics
- Academic Research Institutes
- Other End Users
- Infectious Disease Diagnostics Market Regional Outlook (Revenue, USD Million, 2020 – 2027)
- North America
- S.
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Rest of Asia Pacific
- Central & South America
- Brazil
- Rest of CSA
- Middle East & Africa
- GCC Countries
- South Africa
- Rest of MEA
- North America
Speak With Our Analyst@https://skyquestt.com/speak-with-analyst/infectious-disease-diagnostics-market
List of Key Players of Infectious Disease Diagnostics Market
- Abbott Laboratories (US)
- Hoffmann-La Roche Ltd (Switzerland)
- BioMérieux SA (France)
- Thermo Fisher Scientific Inc. (US)
- Danaher Corporation (US)
- Quidel Corporation(US)
- Hologic, Inc. (US)
- Siemens Healthineers AG (Germany)
- Becton, Dickinson and Company (US)
- PerkinElmer Inc. (US)
- QIAGEN (Netherlands)
- Grifols S.A. (Spain)
- DiaSorin S.p.A (Italy)
- Bio-Rad Laboratories, Inc. (US)
- Sysmex Corporation (Japan)
- Ortho Clinical Diagnostics (US)
- Luminex Corporation (US)
- Meridian Bioscience (US)
- Danaher Corporation (US)
- Mesa Biotech (US)
About Us:
SkyQuest Technology is leading growth consulting firm providing market intelligence, commercialization and technology services. It has 450+ happy clients globally.
Address:
1 Apache Way, Westford, Massachusetts 01886
Phone:
USA (+1) 617-230-0741
Email: sales@skyquestt.com
Find Insightful Blogs/Case Studies on Our Website:
